SCHEMBL2437373

SCHEMBL2437373

CC1(C(N)=O)CCCCC1c1cc2ccccc2[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 6/20 0.42
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
APAF1 O14727 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
SMYD3 Q9H7B4 3/20 0.40
TP53 P04637 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
BRD4 O60885 1/20 0.39
DAO P14920 1/20 0.39
DDO Q99489 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2432421 0.73 KDM4E (0.43) KDM4EALDH1A1TSHRHSD17B10APAF1
SCHEMBL2435589 0.73 KDM4E (0.43) KDM4EALDH1A1TSHRHSD17B10APAF1
SCHEMBL5906965 0.72 CETP (0.40) TSHRLMNACYP3A4
SCHEMBL677495 0.72 BRD4 (0.50) KDM4EALDH1A1TSHRHSD17B10APAF1
SCHEMBL2432424 0.71 DAO (0.41) KDM4EALDH1A1TSHRHSD17B10APAF1
SCHEMBL2913178 0.70 GAA (0.44) KDM4EALDH1A1MEN1KMT2ACYP3A4
SCHEMBL2437366 0.69 ALDH1A1 (0.50) KDM4EALDH1A1TSHRHSD17B10APAF1
SCHEMBL27792401 0.68 DAO (0.53) KDM4EALDH1A1TSHRHSD17B10SMYD3
SCHEMBL32690457 0.68 KDM1A (0.44) LMNACYP3A4MAOB
SCHEMBL29872305 0.68 RBP4 (0.50) KDM4EALDH1A1SMYD3BRD4DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists MERCK SHARP & DOHME LLC 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists NPSR1, NPY1R, NPY2R KDM4E 4352/4885ALDH1A1 4731/4885TSHR 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.